Facts
The Canadian Centre for Ethics in Sport (CCES) alleges Mathieu Marineau, the athlete, for a violation of the Canadian Anti-Doping Program. On June 15, 2014, he underwent a urine test administered out of competition by the CCES. Analysis of the sample showed the presence of SARM S-22 which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.
History
The Athlete requests a B sample analysis. He explained that he had recently received an injection for knee and shoulder pain and that
he would ask his physician whether the injection could be linked to the result of the analysis. The B sample confirmed the findings of the A sample. His physician confirmed that the positive test derived from an injection against inflammation. However an expert in this field explained that the serum of the injection couldn't have been responsible for the positive test. The athlete still claims he has now idea how the prohibited substance had entered his body, this still means he would not be discharged of the burden of establishing the absence of significant fault or negligence.
Decision
The sanction is a two years period of ineligibility beginning on July 8, 2014.
